The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, Wilkinson GR (1998) J Clin Invest 101: 289-94 Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy. Clough LA, D'Agata E, Raffanti S, Haas DW (1999) Clin Infect Dis 29: 75-81; discussion 82-4 Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy. Donahue JP, Dowdy D, Ratnam KK, Hulgan T, Price J, Unutmaz D, Nicotera J, Raffanti S, Becker M, Haas DW (2003) Clin Pharmacol Ther 73: 78-86 Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy. Saah AJ, Haas DW, DiNubile MJ, Chen J, Holder DJ, Rhodes RR, Shivaprakash M, Bakshi KK, Danovich RM, Graham DJ, Condra JH (2003) J Infect Dis 187: 1157-62 Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. Haas DW, Smeaton LM, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, De Gruttola V, Pollard RB, Merigan TC, Hirsch MS, George AL, Donahue JP, Kim RB (2005) J Infect Dis 192: 1931-42 Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384. Grady BJ, Samuels DC, Robbins GK, Selph D, Canter JA, Pollard RB, Haas DW, Shafer R, Kalams SA, Murdock DG, Ritchie MD, Hulgan T, ACTG 384 and DACS 250 Study Teams (2011) J Acquir Immune Defic Syndr 58: 363-70 Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling. Rufo PA, Lin PW, Andrade A, Jiang L, Rameh L, Flexner C, Alper SL, Lencer WI (2004) Am J Physiol Cell Physiol 286: C998-C1008 Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo. Escalante AM, McGrath RT, Karolak MR, Dorr RT, Lynch RM, Landowski TH (2013) Cancer Chemother Pharmacol 71: 1567-76 Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma. Haas DW, Clough LA, Johnson BW, Harris VL, Spearman P, Wilkinson GR, Fletcher CV, Fiscus S, Raffanti S, Donlon R, McKinsey J, Nicotera J, Schmidt D, Shoup RE, Kates RE, Lloyd RM, Larder B (2000) AIDS Res Hum Retroviruses 16: 1491-502
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.